Indolidan structure
|
Common Name | Indolidan | ||
---|---|---|---|---|
CAS Number | 100643-96-7 | Molecular Weight | 257.28800 | |
Density | 1.39g/cm3 | Boiling Point | N/A | |
Molecular Formula | C14H15N3O2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Name | 3,3-dimethyl-5-(6-oxo-4,5-dihydro-1H-pyridazin-3-yl)-1H-indol-2-one |
---|---|
Synonym | More Synonyms |
Density | 1.39g/cm3 |
---|---|
Molecular Formula | C14H15N3O2 |
Molecular Weight | 257.28800 |
Exact Mass | 257.11600 |
PSA | 77.54000 |
LogP | 1.32700 |
Index of Refraction | 1.687 |
RIDADR | UN 3249 |
---|---|
Packaging Group | III |
Hazard Class | 6.1(b) |
~85% Indolidan CAS#:100643-96-7 |
Literature: Robertson; Krushinski; Beedle; Wyss; Pollock; Wilson; Kauffman; Hayes Journal of Medicinal Chemistry, 1986 , vol. 29, # 10 p. 1832 - 1840 |
~% Indolidan CAS#:100643-96-7 |
Literature: Robertson; Krushinski; Beedle; Wyss; Pollock; Wilson; Kauffman; Hayes Journal of Medicinal Chemistry, 1986 , vol. 29, # 10 p. 1832 - 1840 |
~% Indolidan CAS#:100643-96-7 |
Literature: Robertson; Krushinski; Beedle; Wyss; Pollock; Wilson; Kauffman; Hayes Journal of Medicinal Chemistry, 1986 , vol. 29, # 10 p. 1832 - 1840 |
Indolidanum |
Indolidanum [Latin] |
2H-Indol-2-one,1,3-dihydro-3,3-dimethyl-5-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl) |
6-(3,3-dimethyl-2-oxo-indan-5-yl)-4,5-dihydro-2H-pyridazin-3-one |
1,3-dihydro-3,3-dimethyl-5-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)-2H-indol-2-one |
1,3-dihydro-3 |
INDOLIDAN |
3,3-dimethyl-5-(6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)-1,3-dihydro-2H-indol-2-one |
3-dimethyl-5-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)-2H-indol-2-one |